BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38394549)

  • 21. A population-based study of cardiovascular disease mortality risk in US cancer patients.
    Sturgeon KM; Deng L; Bluethmann SM; Zhou S; Trifiletti DM; Jiang C; Kelly SP; Zaorsky NG
    Eur Heart J; 2019 Dec; 40(48):3889-3897. PubMed ID: 31761945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related Disparities in Pan-Cancer Mortality and Causes of Death: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.
    Lin Y; Li H; Wu H; Li S; Abakumov MA; Chekhonin VP; Peltzer K; Abbas KS; Makatsariya AD; Liu Z; Zhang J; Xue Y; Zhang C
    J Cancer; 2024; 15(6):1613-1623. PubMed ID: 38370383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes of death among patients with hepatocellular carcinoma in United States from 2000 to 2018.
    Yang Z; Leng K; Shi G
    Cancer Med; 2023 Jun; 12(12):13076-13085. PubMed ID: 37083308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What Causes Death in Esophageal Cancer Patients Other Than the Cancer Itself: A Large Population-Based Analysis.
    Zheng X; Zhang A; Xiao Y; Guo K; Sun L; Ruan S; Fang F
    J Cancer; 2022; 13(13):3485-3494. PubMed ID: 36313035
    [No Abstract]   [Full Text] [Related]  

  • 25. Analyzing non-cancer causes of death of colorectal carcinoma patients in the US population for the years 2000-2016.
    Lu L; Ma L; Zhang X; Susanne Mullins C; Linnebacher M
    Cancer Med; 2021 Apr; 10(8):2740-2751. PubMed ID: 33314795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causes of death following small cell lung cancer diagnosis: a population-based analysis.
    Wu XQ; Li JY; Du WJ
    BMC Pulm Med; 2022 Jul; 22(1):262. PubMed ID: 35787685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causes of death in long-term bladder cancer survivors: A population-based study.
    Kong J; Diao X; Diao F; Fan X; Zheng J; Yan D; Huang J; Qin H; Lin T
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e167-e174. PubMed ID: 31111675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second Malignant Tumors and Non-Tumor Causes of Death for Patients With Penile Cancer During Their Survivorship.
    Song P; Wu X; Yang L; Ma K; Liu Z; Zhou J; Chen J; Zhu Q; Dong Q
    Cancer Control; 2022; 29():10732748221134789. PubMed ID: 36267038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid.
    Wang S; Ge C
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10203-10215. PubMed ID: 37270459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis.
    Peng FS; Wu WT; Zhang L; Shen JH; Yu DD; Mao LQ
    Front Oncol; 2022; 12():948289. PubMed ID: 36387214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causes of death in long-term lung cancer survivors: a SEER database analysis.
    Abdel-Rahman O
    Curr Med Res Opin; 2017 Jul; 33(7):1343-1348. PubMed ID: 28426338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Causes of Death and Hospitalization in Long-term Lung Cancer Survivors: A Population-based Appraisal.
    Wu GX; Ituarte PHG; Ferrell B; Sun V; Erhunmwunsee L; Raz DJ; Kim JY
    Clin Lung Cancer; 2020 May; 21(3):204-213. PubMed ID: 31591032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causes of death in long-term survivors of head and neck cancer.
    Baxi SS; Pinheiro LC; Patil SM; Pfister DG; Oeffinger KC; Elkin EB
    Cancer; 2014 May; 120(10):1507-13. PubMed ID: 24863390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic mortality risk among cancer patients in the United State SEER population, 1975-2016.
    Zhu X; Heng Y; Zhou L; Zhang M; Cao P; Tao L
    Endocrine; 2020 Nov; 70(2):323-330. PubMed ID: 32643048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Modifiable Health Conditions and Social Determinants of Health With Late Mortality in Survivors of Childhood Cancer.
    Ehrhardt MJ; Liu Q; Dixon SB; Caron E; Redd D; Shelton K; Huang IC; Bhakta N; Ness KK; Mulrooney DA; Brinkman TM; Chemaitilly W; Delaney A; Armstrong GT; Srivastava DK; Zaidi A; Robison LL; Yasui Y; Hudson MM
    JAMA Netw Open; 2023 Feb; 6(2):e2255395. PubMed ID: 36763361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second malignant tumors and non-tumor causes of death for patients with localized and regional kidney cancer after diagnosis.
    Yang L; Wu X; Zhou J; Song P; Liu Z; Chen J; Dong Q
    Eur J Med Res; 2023 Jun; 28(1):206. PubMed ID: 37391781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence features of second primary malignancy among gastric cancer survivors, 1992-2012.
    Li S; Luo Y; Hou Q; Chu H; Zheng H
    Transl Cancer Res; 2020 Nov; 9(11):7001-7011. PubMed ID: 35117306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cause of mortality in 5-year survivors of childhood cancer.
    Mertens AC
    Pediatr Blood Cancer; 2007 Jun; 48(7):723-6. PubMed ID: 17226844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study.
    Mertens AC; Yasui Y; Neglia JP; Potter JD; Nesbit ME; Ruccione K; Smithson WA; Robison LL
    J Clin Oncol; 2001 Jul; 19(13):3163-72. PubMed ID: 11432882
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.